Overview

Staccato Alprazolam and Photoparoxysmal Response

Status:
Completed

Trial end date:
2016-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether people who usually have photosensitive epilepsy will show a reduction in epileptic activity when they take a single dose of Staccato Alprazolam as compared to placebo.

Phase:

Phase 2

Details

Lead Sponsor:

Alexza Pharmaceuticals, Inc.

Collaborator:

The Epilepsy Study Consortium

Treatments:

Alprazolam